Novo Nordisk Q3 earnings lifted by demand for new obesity drug

This post was originally published on this site

Novo reported net profit of 12.1 billion Danish crowns ($1.88 billion) in the third quarter, an 18% increase compared to the same period last year.

($1 = 6.4217 Danish crowns)